Key result
Hepatic lipase -514T allele lowers enzyme activity up to ~30% but does not alter CAD risk.
Case-Control
Answers are grounded in this paper and cite their sources.
Hepatic lipase is an important determinant of plasma HDL concentration and LDL subclass distribution and may therefore influence susceptibility to coronary artery disease (CAD). To assess the effect of genetic variation in hepatic lipase activity on CAD susceptibility, we determined the frequency of the -514T allele of hepatic lipase in white men with CAD and in controls who did not have CAD. In men with CAD, postheparin plasma hepatic lipase activity was 15% to 20% lower in heterozygotes and 30% lower in homozygotes for the -514T allele. Allele frequencies were similar in cases and controls, however, and were consistent with Hardy-Weinberg expectation in both groups. This finding was confirmed in a second group comprising cases with premature symptomatic CAD and controls who were free of disease. These data indicate that a primary decrease in hepatic lipase activity of as much as 30% does not influence susceptibility to CAD in white men.
No takes yet. Share an insight, caveat, or question.
Shohet et al. (1999) conducted a case-control in Coronary artery disease. Hepatic lipase (LIPC) -514T allele polymorphism vs. Non-carriers of the -514T allele was evaluated on Susceptibility to coronary artery disease and postheparin plasma hepatic lipase activity. The hepatic lipase -514T allele lowered enzyme activity by up to 30% in homozygotes without altering CAD susceptibility in white men.
Synapse has enriched 10 related papers. Consider them for comparative context: